These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7717346

  • 21. Parvovirus B19 infection as trigger of graft vs. host disease.
    Behre G, Christopeit M.
    Eur J Haematol; 2008 Nov; 81(5):404. PubMed ID: 18691322
    [No Abstract] [Full Text] [Related]

  • 22. Parvovirus B19 antibodies in patients with haemophilia A.
    Peerlinck K, Goubau P, Reybrouck R, Desmyter J, Vermylen J.
    Thromb Haemost; 1995 Mar; 73(3):555-6. PubMed ID: 7667846
    [No Abstract] [Full Text] [Related]

  • 23. Recurrent human parvovirus B19-induced anemia: initial manifestation of humoral immunodeficiency.
    Murray JC, Paul ME, Rosenblatt HM, McClain KL.
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):97-8. PubMed ID: 8556382
    [No Abstract] [Full Text] [Related]

  • 24. Parvovirus B19 antibodies in sera of patients with unexplained exanthemata from Belém, Pará, Brazil.
    de Freitas RB, de Miranda MF, Shirley J, Tudor R, Desselberger U, Linhares AC.
    Mem Inst Oswaldo Cruz; 1993 Feb; 88(3):497-9. PubMed ID: 8107612
    [No Abstract] [Full Text] [Related]

  • 25. [Human parvovirus B19 infection in a child suffering from chronic arthritis].
    Hosszú E, Sallai A.
    Orv Hetil; 1997 Mar 09; 138(10):611-13. PubMed ID: 9157338
    [Abstract] [Full Text] [Related]

  • 26. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
    Chehadeh W, Halim MA, Al-Nakib W.
    Virology; 2009 Jul 20; 390(1):56-63. PubMed ID: 19450862
    [Abstract] [Full Text] [Related]

  • 27. Human parvovirus B19 infection in children: uncommon clinical presentations.
    Barash J, Dushnitzky D, Sthoeger D, Bardenstein R, Barak Y.
    Isr Med Assoc J; 2002 Oct 20; 4(10):763-5. PubMed ID: 12389336
    [Abstract] [Full Text] [Related]

  • 28. Wegener's granulomatosis and parvovirus B19 infection.
    Nikkari S, Mertsola J, Korvenranta H, Vainionpää R, Toivanen P.
    Arthritis Rheum; 1994 Nov 20; 37(11):1707-8. PubMed ID: 7980681
    [No Abstract] [Full Text] [Related]

  • 29. [Transient pure red cell aplasia in an adult with acute parvovirus B19 infection: observation of PVB19 DNA by polymerase chain reaction, viral antibody and erythroid cells in the bone marrow].
    Kobayashi A, Yoda Y, Yang JY, Namae H, Ishihara N, Nagai H.
    Rinsho Ketsueki; 1993 Apr 20; 34(4):484-9. PubMed ID: 8510337
    [Abstract] [Full Text] [Related]

  • 30. Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niterói city area, State of Rio de Janeiro, Brazil).
    Oliveira SA, Camacho LA, Pereira AC, Faillace TF, Setubal S, Nascimento JP.
    Mem Inst Oswaldo Cruz; 2002 Oct 20; 97(7):965-70. PubMed ID: 12471422
    [Abstract] [Full Text] [Related]

  • 31. Chronic parvovirus infection in a presumably immunologically healthy woman.
    Faden H, Gary GW, Anderson LJ.
    Clin Infect Dis; 1992 Oct 20; 15(4):595-7. PubMed ID: 1330011
    [Abstract] [Full Text] [Related]

  • 32. [Parvovirus B19 infection revealed by acute renal insufficiency].
    Leray H, Canaud B, Cristol JP, Jonquet O, Daprès G, Ortiz JP, Mion C.
    Nephrologie; 1992 Oct 20; 13(3):123-5. PubMed ID: 1641054
    [Abstract] [Full Text] [Related]

  • 33. Parvovirus B19 infection--an emerging infectious disease?
    Rahav G.
    Isr Med Assoc J; 2002 Oct 20; 4(10):810-1. PubMed ID: 12389346
    [No Abstract] [Full Text] [Related]

  • 34. Seroprevalence of parvovirus B19 among HIV-1-positives in Japan.
    Taguchi H, Yamada T, Takahashi T, Gotoh M, Nakamura T, Iwamoto A.
    Jpn J Infect Dis; 2000 Feb 20; 53(1):21. PubMed ID: 10777855
    [No Abstract] [Full Text] [Related]

  • 35. Recurrent erythema in patients with long-term parvovirus B19 infection.
    Musiani M, Manaresi E, Gallinella G, Cricca M, Zerbini M.
    Clin Infect Dis; 2005 Jun 15; 40(12):e117-9. PubMed ID: 15909254
    [Abstract] [Full Text] [Related]

  • 36. Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins.
    Palmer P, Pallier C, Leruez-Ville M, Deplanche M, Morinet F.
    Clin Diagn Lab Immunol; 1996 Mar 15; 3(2):236-8. PubMed ID: 8991644
    [Abstract] [Full Text] [Related]

  • 37. Presumed parvovirus B19-associated retinal pigment epitheliopathy.
    Grand MG, Storch GA.
    Retina; 2000 Mar 15; 20(2):199-202. PubMed ID: 10783955
    [Abstract] [Full Text] [Related]

  • 38. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection.
    Jones LP, Erdman DD, Anderson LJ.
    J Infect Dis; 1999 Aug 15; 180(2):500-4. PubMed ID: 10395869
    [Abstract] [Full Text] [Related]

  • 39. [Parvovirus B19 (PV-B19) and the human diseases it causes].
    Iavorkovskiĭ LI.
    Ter Arkh; 1995 Aug 15; 67(11):56-8. PubMed ID: 8571256
    [Abstract] [Full Text] [Related]

  • 40. Bilateral brachial plexus neuritis following parvovirus B19 and cytomegalovirus infection.
    Maas JJ, Beersma MF, Haan J, Jonkers GJ, Kroes AC.
    Ann Neurol; 1996 Dec 15; 40(6):928-32. PubMed ID: 9007101
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.